Nanomedical research in Australia and New Zealand

Nanomedicine (Lond). 2013 Dec;8(12):1999-2006. doi: 10.2217/nnm.13.179.

Abstract

Although Australia and New Zealand have a combined population of less than 30 million, they have an active and interlinked community of nanomedical researchers. This report provides a synopsis and update on this network with a view to identifying the main topics of interest and their likely future trajectories. In addition, our report may also serve to alert others to opportunities for joint projects. Australian and New Zealand researchers are engaged in most of the possible nanomedical topics, but the majority of interest is focused on drug and nucleic acid delivery using nanoparticles or nanoporous constructs. There are, however, smaller programs directed at hyperthermal therapy and radiotherapy, various kinds of diagnostic tests and regenerative technologies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Australia
  • Diagnostic Techniques and Procedures
  • Drug Delivery Systems* / methods
  • Humans
  • Nanomedicine* / methods
  • Nanostructures / chemistry
  • Nanostructures / therapeutic use
  • New Zealand
  • Nucleic Acids / administration & dosage*
  • Pharmaceutical Preparations / administration & dosage*
  • Regenerative Medicine* / methods

Substances

  • Nucleic Acids
  • Pharmaceutical Preparations